JP2007145794A - Composition for ameliorating and/or preventing skin disorder - Google Patents

Composition for ameliorating and/or preventing skin disorder Download PDF

Info

Publication number
JP2007145794A
JP2007145794A JP2006047436A JP2006047436A JP2007145794A JP 2007145794 A JP2007145794 A JP 2007145794A JP 2006047436 A JP2006047436 A JP 2006047436A JP 2006047436 A JP2006047436 A JP 2006047436A JP 2007145794 A JP2007145794 A JP 2007145794A
Authority
JP
Japan
Prior art keywords
acid
composition
thioctic
thioctic acid
skin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006047436A
Other languages
Japanese (ja)
Other versions
JP5023311B2 (en
Inventor
Takashi Takashita
崇 高下
Takeo Ishihara
健夫 石原
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BHN Co Ltd
Original Assignee
BHN Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BHN Co Ltd filed Critical BHN Co Ltd
Priority to JP2006047436A priority Critical patent/JP5023311B2/en
Publication of JP2007145794A publication Critical patent/JP2007145794A/en
Application granted granted Critical
Publication of JP5023311B2 publication Critical patent/JP5023311B2/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Non-Alcoholic Beverages (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

<P>PROBLEM TO BE SOLVED: To provide a composition for ameliorating and/or preventing skin disorder caused by the irradiation with ultraviolet rays; and to provide a composition in a mode state in which the composition can be effectively utilized in the industry. <P>SOLUTION: The composition comprises thioctic acids and/or chitin hydrolyzate as an active ingredient, wherein the thioctic acids are preferably thioctic acid, a derivative of the thioctic acid, a lipid-covered product thereof or a doubly covered product obtained by covering the lipid-covered product with a hydrophilic material, and the chitin hydrolyzate is preferably N-acetyl-D-glucosamine or N-acetylchitooligosaccharide. The oral composition of a food and drink or the like for ameliorating and/or preventing skin disorder caused by the irradiation with the ultraviolet rays contains the active ingredient. <P>COPYRIGHT: (C)2007,JPO&INPIT

Description

本発明は、チオクト酸類及び/又はキチン加水分解物を有効成分として含有してなることを特徴とする、紫外線照射による皮膚障害の改善及び/又は予防のための組成物及び前記有効成分の使用方法に係り、又、前記組成物を含有してなる飲食品等の経口用組成物に関するものである。The present invention comprises a thioctic acid and / or chitin hydrolyzate as an active ingredient, a composition for improving and / or preventing skin damage caused by ultraviolet irradiation, and a method of using the active ingredient In addition, the present invention relates to oral compositions such as foods and drinks containing the composition.

近年の地球環境の変化(温暖化、オゾン層の破壊等)にともない地球上の生物が受ける紫外線量は、現在は概ね許容範囲内にあるとされながらも増加傾向にあり、人においては、従来の皮膚美容のみならず健康に対する影響に関心が高まっている。紫外線による皮膚への影響としてシミ、そばかす、黒皮等の色素沈着、シワ、たるみ等の皮膚組織の老化を誘発及び促進し、又、とりわけ欧米地域では皮膚癌の多発が懸念されている。With recent changes in the global environment (warming, destruction of the ozone layer, etc.), the amount of ultraviolet rays received by organisms on the earth is currently increasing, although it is generally within an acceptable range. There is growing interest in health effects as well as skin beauty. As an effect on the skin by ultraviolet rays, it induces and promotes aging of skin tissues such as stains, freckles, and black skin, wrinkles, sagging, etc. In particular, there are concerns about the frequent occurrence of skin cancer particularly in the western region.

紫外線が皮膚に及ぼす影響について次のようなことが知られている。太陽光に含まれる紫外線のうち、長波長の紫外線(400nm〜320nm、UV−A)は、細胞の物質代謝に関与して細胞機能を活性化させ、皮膚の日焼け(褐色化)を生じさせる。又、真皮層に作用して蛋白質を変性させ、コラーゲンやエラスチンを変性させて皮膚の弾力性を失わせてシワやたるみの原因をつくり、皮膚の老化を促進する。光毒性あるいは光アレルギー反応を誘発する場合もあり、UV−Bによって生成されるメラニン色素を酸化して褐色に変化させる。中波長の紫外線(320nm〜280nm、UV−B)は、表皮層に作用するが、色素細胞がメラニンを生成して生体組織を防御する。肌を赤く日焼け(サンバーン)させ、炎症、紅斑、水泡を生じさせ、シミ、ソバカス等の形成の一因であると考えられている。又、大量に浴びると免疫低下、皮膚癌、白内障等を誘発するといわれている。短波長の紫外線(280nm未満、UV−C)は強い殺菌作用を有し、生体に対する破壊性が最も強いが、290nm以下の紫外線は大気圏のオゾン、大気中の酸素や窒素によって吸収されるため地上には到達しない、The following is known about the effect of ultraviolet rays on the skin. Among ultraviolet rays contained in sunlight, long-wavelength ultraviolet rays (400 nm to 320 nm, UV-A) are involved in cellular metabolism of the cells to activate cell functions and cause skin tanning (browning). In addition, it acts on the dermis layer to denature proteins and collagen and elastin to denature the skin, thereby causing skin wrinkles and sagging to promote skin aging. In some cases, phototoxicity or photoallergic reaction is induced, and the melanin pigment produced by UV-B is oxidized to turn brown. Medium wavelength ultraviolet light (320 nm to 280 nm, UV-B) acts on the epidermis layer, but pigment cells generate melanin to protect living tissues. It is considered that the skin is tanned (sunburn) red, causing inflammation, erythema and blisters, and contributing to the formation of spots, freckles and the like. In addition, it is said that a large amount of exposure induces immune decline, skin cancer, and cataract. Short wavelength ultraviolet rays (less than 280 nm, UV-C) have a strong bactericidal action and are most destructive to living organisms, but ultraviolet rays below 290 nm are absorbed by atmospheric ozone, oxygen and nitrogen in the atmosphere, so Does not reach,

かかる紫外線とりわけUV−AやUV−Bによる皮膚障害を予防、改善又は治療するために、従来の皮膚外用剤には桂皮酸系化合物、アミノ安息香酸誘導体、ベンゾフェノン誘導体、サリチル酸系化合物、ウロカニン酸誘導体等の紫外線吸収剤、酸化亜鉛、酸化チタン等の紫外線遮蔽剤が利用されてきた。しかしながら、例えば、桂皮酸系誘導体には光毒性を示すものがあり、アミノ安息香酸類は変色や樹脂状物質に変性することがある等安全性や安定性、使用性、コスト等の問題から、必ずしも十分な効果が得られていたわけではなかった。In order to prevent, ameliorate, or treat skin damage caused by ultraviolet rays, particularly UV-A and UV-B, conventional skin external preparations include cinnamic acid compounds, aminobenzoic acid derivatives, benzophenone derivatives, salicylic acid compounds, urocanic acid derivatives. UV absorbers such as zinc oxide and titanium oxide have been used. However, for example, some cinnamic acid derivatives exhibit phototoxicity, and aminobenzoic acids may be discolored or denatured into a resinous substance, for example, because of safety, stability, usability, cost, etc. A sufficient effect was not obtained.

又、紫外線照射による皮膚障害を予防、改善あるいは治療するための様々な飲食物が提案されている。すなわち、甘蔗由来エキスを有効成分とする放射線障害抑制剤及びこれを含む食品(特許文献1)、有機亜鉛化合物を含有する紫外線誘導活性酸素抑制剤及びこれを含む食品(特許文献2)、ヤマノイモ科植物の根茎部又はその抽出物からなる経口摂取用皮膚改善剤(特許文献3)、トコフェロール誘導体を含む抗酸化剤及びこれを含有する紫外線防止剤並びに食品(特許文献4)、パパイヤとアロエを組み合わせた小じわ予防食品(特許文献5)、紫外線吸収剤として2−O−α−D−グルコシル−L−アスコルビン酸を含有する飲食物(特許文献6)等がある。In addition, various foods and drinks for preventing, improving, or treating skin damage caused by ultraviolet irradiation have been proposed. That is, a radiation damage inhibitor containing a sweet potato-derived extract as an active ingredient and a food containing the same (Patent Document 1), an ultraviolet-induced active oxygen inhibitor containing an organic zinc compound and a food containing the same (Patent Document 2), Combining papaya and aloe, a skin improving agent for oral consumption consisting of a rhizome of a plant or an extract thereof (Patent Document 3), an antioxidant containing a tocopherol derivative, an ultraviolet light inhibitor containing the same, and a food (Patent Document 4) There are foods and drinks (Patent Document 6) containing 2-O-α-D-glucosyl-L-ascorbic acid as a UV absorber.

これらは、有効成分とする所定の成分物質を経口摂取することにより、該物質が体内代謝メカニズムの一環として皮膚組織機能の衰弱、劣化又は損傷を回復させることを期待するものであるが、実用面では消化器系で分解や変質がおき、吸収性が劣り、皮膚組織への移送が遅い等の難点があり、十分な所望効果を発現するものが数少ないのが実情であった。These are expected to restore the weakness, deterioration or damage of skin tissue function as part of the body's metabolic mechanism by ingesting a prescribed component substance as an active ingredient. In the digestive system, however, there are problems such as degradation and alteration, poor absorbability, slow transfer to the skin tissue, etc., and there are few things that exhibit sufficient desired effects.

ところで、後述するチオクト酸については次のようなことが知られてる。チオクト酸は、α−リポ酸、1,2−ジエチレン−3−ペンタン酸、1,2−ジエチレン−3−吉草酸、1,2−ジチオラン−6−ペンタン酸又は1,2−ジチアシクロペンタン−3−吉草酸等とも称せられる。淡黄色ないし黄色の結晶ないし結晶性粉末で、特異臭を有し、融点がラセミ体:60〜61℃、R体:46〜48℃、S体:45〜48℃であり、水にわずかに溶け、エタノール、アセトン等の有機溶剤や希アルカリ水に溶解する性質をもつ。チオクト酸は植物、動物・ヒト、微生物の生体内で合成され、細胞のエネルギー産生に係る補酵素として知られ、グルコース解糖系から生じるピルビン酸、α−ケトグルタル酸等のα−ケト酸類の酸化的脱炭酸反応(例えば、生体のエネルギー産生系におけるピルビン酸からアセチルコエンザイムAへの変換)を触媒することが知られている。By the way, the following things are known about the thioctic acid mentioned later. Thioctic acid is α-lipoic acid, 1,2-diethylene-3-pentanoic acid, 1,2-diethylene-3-valeric acid, 1,2-dithiolane-6-pentanoic acid or 1,2-dithiacyclopentane. It is also called -3-valeric acid. Pale yellow to yellow crystal or crystalline powder with specific odor, melting point: racemic: 60-61 ° C, R: 46-48 ° C, S: 45-48 ° C, slightly in water Dissolves and dissolves in organic solvents such as ethanol and acetone and dilute alkaline water. Thioctic acid is synthesized in the living body of plants, animals / humans, and microorganisms, and is known as a coenzyme for cell energy production. Oxidation of α-keto acids such as pyruvate and α-ketoglutarate produced from glucose glycolysis It is known to catalyze a decarboxylation reaction (for example, conversion of pyruvic acid to acetyl coenzyme A in a living energy production system).

近年、チオクト酸及びその還元型ジヒドロチオクト酸(6,8−ジメルカプト−オクタン酸)の機能に関する研究が進み、これらは強力な抗酸化力を有することが注目されており、スーパーオキシドラジカル、ヒドロキシラジカル、ペルオキシラジカル、一重項酸素等の活性酸素種と親和性が高く容易に反応して活性酸素種の作用を失わしめ、生体組織へのダメージを低減させ、ビタミンCやグルタチオンとの相互作用により細胞膜を保護し、又、ビタミンEを再生する効力を有するといわれている(非特許文献1)。チオクト酸の薬理作用については、虚血性再灌流時の組織損傷、糖尿病、白内障、神経変性、放射線障害、炎症性疾患等の酸化ストレスの病態モデルに対して有効であることが報告されている(非特許文献2)。チオクト酸と紫外線照射による皮膚障害との関連性について、紫外線照射による光誘発性のケラチノサイト細胞溶解因子の生成を阻害し、コラーゲン等の膠原繊維の分解を防止するための経口投与可能なα−リポ酸含有組成物が提案されている(特許文献7)。In recent years, research on the functions of thioctic acid and its reduced dihydrothioctic acid (6,8-dimercapto-octanoic acid) has progressed, and these have attracted attention as having strong antioxidative properties. It reacts easily with reactive oxygen species such as peroxy radicals and singlet oxygen, easily reacting to lose the action of reactive oxygen species, reducing damage to living tissue, and interacting with vitamin C and glutathione It is said that it has the effect of protecting vitamins and regenerating vitamin E (Non-patent Document 1). The pharmacological action of thioctic acid has been reported to be effective for pathological models of oxidative stress such as tissue damage during ischemic reperfusion, diabetes, cataracts, neurodegeneration, radiation damage, inflammatory diseases, etc. ( Non-patent document 2). Regarding the relationship between thioctic acid and skin damage caused by ultraviolet irradiation, α-liposome that can be administered orally to inhibit the production of light-induced keratinocyte cell lysis factor by ultraviolet irradiation and prevent the degradation of collagen fibers such as collagen An acid-containing composition has been proposed (Patent Document 7).

又、後述するキチン加水分解物については次のことが公知である。すなわち、エビ、蟹、オキアミ等の甲殻類の皮(甲殻)はキチン質であり、基本的にN−アセチルグルコサミンがβ−1,4結合した直鎖状の多糖類であるキチンで構成されている。キチン質原料を酸で脱カルシウム処理、アルカリで脱蛋白処理し、適宜に爆砕、膨滑化あるいはコロイド化等の前処理を施し、塩酸、硫酸等の強酸及び/又はキチナーゼ、リゾチーム、キトビアーゼ、N−アセチルグルコサミニダーゼ、N−アセチルヘキソサミニダーゼ等の酵素を作用させて加水分解反応せしめると、N−アセチルキトオリゴ糖及び/又はN−アセチルグルコサミンを含有するキチン加水分解物を製造することができる。Moreover, the following is well-known about the chitin hydrolyzate mentioned later. That is, the crustacean skin (crustacea) such as shrimp, shark and krill is chitinous, and is basically composed of chitin which is a linear polysaccharide in which N-acetylglucosamine is linked by β-1,4. Yes. Chitin raw material is decalcified with acid, deproteinized with alkali, pretreated appropriately, such as explosion, swelling or colloid, strong acid such as hydrochloric acid, sulfuric acid and / or chitinase, lysozyme, chitobiase, N -When an enzyme such as acetylglucosaminidase or N-acetylhexosaminidase is allowed to act to cause a hydrolysis reaction, a chitin hydrolyzate containing N-acetylchitooligosaccharide and / or N-acetylglucosamine can be produced. .

N−アセチルキトオリゴ糖及び/又はN−アセチルグルコサミンは、甘味料、ビフィズス菌等の腸内細菌の増殖促進物質、食品素材にボディ感の付与剤等として利用することができ、N−アセチルキトオリゴ糖のうちN−アセチルキトヘキサオースはマウスの固形腫瘍種(Sarcoma−180、MM−46、Meth−A等)に対して増殖阻害作用を有すること(非特許文献3及び非特許文献4)、N−アセチルキトテトラオースからN−アセチルキトへプタオースまでのキトオリゴ糖は好中球の免疫活性を亢進する作用があること(非特許文献5)等の生理活性が報告されている。N-acetylchitooligosaccharide and / or N-acetylglucosamine can be used as a sweetener, a substance that promotes the growth of intestinal bacteria such as bifidobacteria, a food material, and a body feeling imparting agent. Among oligosaccharides, N-acetylchitohexaose has a growth inhibitory action on mouse solid tumor types (Sarcoma-180, MM-46, Meth-A, etc.) (Non-patent Documents 3 and 4) Physiological activities such as that chitooligosaccharides from N-acetylchitotetraose to N-acetylchitoheptaose have the effect of enhancing the neutrophil immune activity have been reported (Non-patent Document 5).

又、粉末や粒子等を芯物質としてその表面周囲を高分子物質や脂質等の疎水性物質で被覆する技術は従来から知られており、かかる被覆処理によって芯物質の味や香りを安定に保持させたり、吸湿を防止したり、粉体流動性を改善し、あるいは芯物質が水溶性成分である場合の該成分の漏出を防止したりすることが提案されている。しかし、かかる被覆処理による芯物質の保護作用は、香味成分等の品質保持、防湿性、水溶性成分の漏出防止等の効果をねらいとしたものである、In addition, the technology of coating powders and particles as a core substance and surrounding the surface with a hydrophobic substance such as a polymer substance or lipid has been known, and the coating process stably maintains the taste and aroma of the core substance. It has been proposed to prevent or absorb moisture, improve powder flowability, or prevent leakage of the component when the core substance is a water-soluble component. However, the protective action of the core material by such coating treatment is aimed at maintaining the quality of flavor components, moisture resistance, prevention of leakage of water-soluble components, etc.

特開2005−75750号公報JP-A-2005-75750 特開2004−277308号公報JP 2004-277308 A 特開2004−67663号公報JP 2004-67663 A 特開2001−279242号公報JP 2001-279242 A 特開平11−253129号公報JP 11-253129 A 特開平3−139288号公報JP-A-3-139288 特開2005−132823号公報JP 2005-132823 A Kagan V.E.等、“Dihydrolipoic acid−A universal antioxidant both in the membrane and in the aqueous phase. Reduction of peroxyl,ascorbyl and chromanoxyl radicals.”(アメリカ)、1992年、Biochem.Pharmacol.、第44巻、第8号、第1637頁〜第1649頁Kagan V.K. E. Et al., “Dihydrolipoic acid-A universal antixidant both in the membrane and in the aqueous phase. Reduction of peroxyl, ascorbyl and ascorbyl. Pharmacol. 44, No. 8, pp. 1637-1649 Indrahi Maitra等、“α−lipoic acid preventsbuthionine sulfoximine−induced cataractformation in newborn rats.”(オランダ)、1995年、Free Radical Biology and Medicine、第18巻、4月号、第823頁〜第829頁Indrahi Maitra et al., “Α-lipoic acid preventsbuthineine sulfoximine-induced catalyst formation in newborn rats.” (Netherlands), p. 8, No. 8, M A.Tokoro等、“Growth−inhibitory effect of hexa−N−acetylchitohexaose and chitohexaose against Meth−A solid tumor.”(日本)、1988年、Chem.Pharm.Bull.、第36巻、第784頁〜第790頁A. Tokoro et al., “Growth-inhibitory effect of hexa-N-acetylchitohexaose and chitohexaose aginest Meth-A solid tumor.” (Japan), Chem. Pharm. Bull. 36, p. 784-p. 790 K.Suzuki等、“Antitumor effect of hexa−N−acetylchitohexaose and chitohexaose.”(オランダ)、1986年、Carbohydr,Res.、第151巻、第403頁〜第408頁K. Suzuki et al., “Antitutor effect of hexa-N-acetylchitohexose and chitohexaose” (Netherlands), 1986, Carbohydr, Res. 151, pp. 403-408 S.Suzuki等、“Chitin in Nature and Technology”編集R.Muzzarelli等(アメリカ)、1985年、Plenum.New York、第485頁〜第492頁S. Suzuki et al., “Chitin in Nature and Technology”. Muzzarelli et al. (USA), 1985, Plenum. New York, pp. 485-492.

かかる現状に鑑み、本発明者らは、経口摂取することによって紫外線照射による皮膚障害を顕著に予防、改善又は治療し得る安全かつ安定な素材を開発し、これを産業上有効に活用できる態様の組成物を提供することを課題とした。In view of the current situation, the present inventors have developed a safe and stable material that can significantly prevent, ameliorate, or treat skin damage caused by ultraviolet irradiation by ingestion, and can be effectively utilized industrially. An object was to provide a composition.

前記課題を解決するために、本発明者らは、紫外線とりわけUV−B照射による皮膚障害を効果的に予防、改善する素材について鋭意検討を重ねた結果、チオクト酸類とキチン分解物が意外にも顕著な効果を奏すること、又、これらを飲食品、飼料、化粧品、医薬品等の分野に有効利用できることを見出し、本発明を完成するに至った。In order to solve the above-mentioned problems, the present inventors have made extensive investigations on materials that effectively prevent and improve skin damage caused by ultraviolet rays, particularly UV-B irradiation. As a result, the thioctic acids and chitin degradation products are surprisingly different. The inventors have found that the present invention has remarkable effects, and that these can be effectively used in the fields of foods and drinks, feeds, cosmetics, pharmaceuticals and the like, and have completed the present invention.

すなわち、本発明によれば、チオクト酸類及び/又はキチン加水分解物を有効成分として含有してなることを特徴とする紫外線照射による皮膚障害の改善及び/又は予防のための組成物が提供される。That is, according to the present invention, there is provided a composition for improving and / or preventing skin damage caused by ultraviolet irradiation, comprising thioctic acids and / or chitin hydrolysates as active ingredients. .

前記組成物において、チオクト酸類はチオクト酸、その還元体、それらの光学ラセミ体、それらの塩、エステル並びにアミド、及びこれらのシクロデキストリン包接物からなる群から選ばれる1種又は2種以上のものであることが望ましく、更には、チオクト酸、その還元体、それらの光学ラセミ体、それらの塩、エステル及びアミドからなる群から選ばれる1種又は2種以上の結晶、粉末及び/又は粒子の外表面を脂質類で被覆してなるものがより望ましい。In the composition, the thioctic acids are one or more selected from the group consisting of thioctic acid, its reduced form, their optical racemate, their salts, esters and amides, and these cyclodextrin inclusion products. Furthermore, it is desirable that the thioctic acid, its reduced form, their optical racemate, their salts, esters and amides, one or more crystals, powder and / or particles. More preferably, the outer surface is coated with lipids.

又、前記組成物において、キチン加水分解物は、キチンを酸及び酵素の少なくとも一方を用いて加水分解処理して得られるものであることが望ましく、更には、N−アセチルキトオリゴ糖及び/又はN−アセチルグルコサミンを主たる成分として含有するものがより好ましい。In the above composition, the chitin hydrolyzate is preferably obtained by hydrolyzing chitin with at least one of an acid and an enzyme, and further, N-acetylchitooligosaccharide and / or What contains N-acetylglucosamine as a main component is more preferable.

尚、前記組成物が改善及び/又は予防するための皮膚障害とは、紫外線照射による皮膚の炎症、硬化、肥厚及び肌荒れのうち少なくとも1つの症状を有するものを対象とすることがより好適である。The skin disorder for improving and / or preventing the composition is more preferably intended for those having at least one symptom of skin inflammation, hardening, thickening and rough skin caused by ultraviolet irradiation. .

本発明によれば、又、前記の紫外線照射による皮膚障害の改善及び/又は予防のための組成物を含有してなることを特徴とする経口用組成物が提供され、この経口用組成物は飲食品であることが望ましい。更に、紫外線照射によるヒトの皮膚障害を改善及び/又は予防するために、チオクト酸類及び/又はキチン加水分解物を使用する方法が提供され、該使用方法は経口摂取又は経口投与であることが望ましい。According to the present invention, there is also provided an oral composition characterized in that it comprises a composition for improving and / or preventing skin damage caused by ultraviolet irradiation, and the oral composition is It is desirable to be a food or drink. Furthermore, a method of using thioctic acids and / or chitin hydrolyzate is provided in order to improve and / or prevent human skin damage caused by ultraviolet irradiation, and the method of use is preferably ingested or administered orally. .

本発明の組成物は、品質の安定性に優れ、これを経口的に摂取することにより、有効成分が体内で消化分解されることなく効率的に吸収され、紫外線とりわけUV−B照射によって生じる炎症を抑制し、皮膚の硬化や肥厚を防ぎ、肌荒れを防止及び/又は治療することができる。このため、本発明の組成物は、飲食品、飼料、医薬品等の分野において、前記組成物のままで又は従来の各種製品に配合した形態で有効活用することが可能となる。本発明の組成物は又、皮膚に適用しても前記同様の効果を奏することができ、皮膚外用剤としても有効利用することが可能である。The composition of the present invention has excellent quality stability, and when taken orally, the active ingredient is efficiently absorbed without being digested and decomposed in the body, and inflammation caused by ultraviolet rays, particularly UV-B irradiation. Can be suppressed, skin hardening and thickening can be prevented, and rough skin can be prevented and / or treated. For this reason, the composition of the present invention can be effectively used as it is in the above-mentioned composition or in a form blended with various conventional products in the fields of foods and drinks, feeds, pharmaceuticals and the like. The composition of the present invention can also exhibit the same effects as described above even when applied to the skin, and can be effectively used as an external preparation for skin.

以下に本発明を詳細に説明する。本発明において、紫外線は前述のUV−A及びUV−Bを含む波長範囲の光線をさすが、とりわけUV−Bを対象にすることが好適である。又、紫外線照射による皮膚障害とは、正常な皮膚組織の機能が退行、劣化あるいは低減することによって発現する異状のことであり、その中でも皮膚の炎症、硬化、肥厚及び肌荒れのうち少なくとも1つの症状を呈するものを対象にすることが好適であり、更には皮膚の硬化及び/又は肥厚を呈するものがより好適である。The present invention is described in detail below. In the present invention, ultraviolet rays refer to light rays in the wavelength range including the above-mentioned UV-A and UV-B, and it is particularly preferable to target UV-B. Skin damage caused by ultraviolet irradiation is an abnormality that develops when the function of normal skin tissue is degenerated, deteriorated or reduced, and among them, at least one symptom of skin inflammation, hardening, thickening and rough skin. It is preferable to target those exhibiting the above, and more preferable are those exhibiting skin hardening and / or thickening.

本発明に係る組成物は、紫外線照射による皮膚障害の改善及び/又は予防のために用いられるものであり、チオクト酸類及び/又はキチン加水分解物を有効成分として含有してなることを特徴とする。The composition according to the present invention is used for improvement and / or prevention of skin damage caused by ultraviolet irradiation, and is characterized by containing thioctic acids and / or chitin hydrolysates as active ingredients. .

ここで、チオクト酸類の起源や種類は特に限定されるものではなく、牛や豚の肝臓等臓器の天然物抽出物や、例えば、エチレン及びアジピン酸エステルを出発原料とする化学的合成品等公知の方法で採取、製造されたものでよい。尚、チオクト酸は不斉炭素を有するため光学的に鏡像異性体((R)−エナンチオマー及び(S)−エナンチオマー)が存在するが、本発明に係るチオクト酸はこれらのいずれか単独でも任意割合の混合物でもよく、又、ラセミ混合物やラセミ体でも差し支えない。工業生産レベルの実施においては、安価で容易に入手できる市販ラセミ体を利用するのが簡便であり、ラセミ体を用いると本発明の所望の効果をより強力に発現する傾向が大きいので望ましい。Here, the origin and type of thioctic acids are not particularly limited, and natural product extracts of organs such as livers of cattle and pigs, and chemical synthetic products starting from ethylene and adipic acid esters are known. It may be collected and manufactured by the method described above. In addition, since thioctic acid has an asymmetric carbon, optically enantiomers ((R) -enantiomer and (S) -enantiomer) exist, but any one of these thioctic acids according to the present invention can be used in any proportion. Or a racemic mixture or a racemate. In the implementation of the industrial production level, it is easy to use a commercially available racemic body that is inexpensive and easily available, and it is desirable to use the racemic body because the desired effect of the present invention is more strongly expressed.

本発明に係る組成物に使用するチオクト酸類は、前記のチオクト酸のほか各種誘導体を適宜に利用することができるが、その還元体、光学ラセミ体、それらの塩、エステル並びにアミド、及びシクロデキストリン包接物からなる群から選択される1種又は2種以上のものであることが望ましい。チオクト酸の還元体の具体例としてジヒドロチオクト酸、ジヒドロリポ酸、6,8−ジメルカプト−オクタン酸等を挙げることができ、同様に光学ラセミ体としては(R),(S)−チオクト酸、(R),(S)−ジヒドロチオクト酸等、塩としては(R)−チオクト酸、(S)−チオクト酸、(R),(S)−チオクト酸、(R)−ジヒドロチオクト酸、(S)−ジヒドロチオクト酸、(R),(S)−ジヒドロチオクト酸等のカリウム塩、ナトリウム塩、カルシウム塩、マグネシウム塩等、エステルとしては(R)−チオクト酸、(S)−チオクト酸、(R),(S)−チオクト酸、(R)−ジヒドロチオクト酸、(S)−ジヒドロチオクト酸、(R),(S)−ジヒドロチオクト酸等と多価アルコール(エチレングリコール、プロピレングリコール、ブタンジオール、ネオペンチルグリコール、グリセリン、エリスリトール、ポリグリセリン等のモノマーないしポリマー)との部分エステル若しくは完全エステル又はグリセリド類(モノグリセリド、ジグリセリド、トリグリセリド)、あるいは炭素数10〜22の高級アルコール類(デカノール、ラウリルアルコール、ミリスチルアルコール、セタノール、ステアリルアルコール、イソステアリルアルコール、ベヘニルアルコール等)とのモノエステル等、アミドとしては(R)−チオクト酸、(S)−チオクト酸、(R),(S)−チオクト酸、(R)−ジヒドロチオクト酸、(S)−ジヒドロチオクト酸、(R),(S)−ジヒドロチオクト酸等のアミドを例示することができる。又、シクロデキストリン包接物はα−、β−、γ−又はδ−シクロデキストリンと前記チオクト酸又はその誘導体との包接物を例示することができる。尚、本発明はこれらの例示によって限定されるものではない。As the thioctic acids used in the composition according to the present invention, various derivatives in addition to the above thioctic acid can be used as appropriate, and their reduced forms, optical racemates, salts thereof, esters and amides, and cyclodextrins. It is desirable to be one or more selected from the group consisting of inclusions. Specific examples of the reduced form of thioctic acid include dihydrothioctic acid, dihydrolipoic acid, 6,8-dimercapto-octanoic acid and the like. Similarly, optical racemates include (R), (S) -thioctic acid, ( (R), (S) -dihydrothioctic acid and the like, (R) -thioctic acid, (S) -thioctic acid, (R), (S) -thioctic acid, (R) -dihydrothioctic acid, (S ) -Dihydrothioctic acid, potassium salts such as (R), (S) -dihydrothioctic acid, sodium salts, calcium salts, magnesium salts, etc. Examples of esters include (R) -thioctic acid, (S) -thioctic acid, ( R), (S) -thioctic acid, (R) -dihydrothioctic acid, (S) -dihydrothioctic acid, (R), (S) -dihydrothioctic acid and the like and polyhydric alcohols (ethylene glycol, propylene Partial esters or complete esters or glycerides (monoglycerides, diglycerides, triglycerides) with glycol, butanediol, neopentyl glycol, glycerin, erythritol, polyglycerin, etc., or higher alcohols having 10 to 22 carbon atoms ( Monoesters with decanol, lauryl alcohol, myristyl alcohol, cetanol, stearyl alcohol, isostearyl alcohol, behenyl alcohol, etc.) and amides include (R) -thioctic acid, (S) -thioctic acid, (R), (S) Examples include amides such as -thioctic acid, (R) -dihydrothioctic acid, (S) -dihydrothioctic acid, and (R), (S) -dihydrothioctic acid. The cyclodextrin inclusion product may be an inclusion product of α-, β-, γ- or δ-cyclodextrin and the thioctic acid or a derivative thereof. In addition, this invention is not limited by these illustrations.

本発明では、チオクト酸類として前記のチオクト酸、その還元体、光学ラセミ体、それらの塩、エステル並びにアミド、及びこれらのシクロデキストリン包接物からなる群から選ばれる1種又は2種以上の結晶,粉末及び/又は粒子の外表面を脂質類で被覆してなるものも包含し、この態様はチオクト酸類の熱的変質(分解、重合、変色等)、吸湿あるいは酸化的変性を抑制するため更に望ましいものである。In the present invention, one or more crystals selected from the group consisting of the above-mentioned thioctic acid, its reduced form, optical racemate, their salts, esters and amides, and these cyclodextrin inclusion products as thioctic acids. , Powders and / or particles whose outer surface is coated with lipids, and this embodiment further suppresses thermal alteration (decomposition, polymerization, discoloration, etc.), moisture absorption or oxidative modification of thioctic acids. Is desirable.

前記チオクト酸類の結晶、粉末及び/又は粒子の外表面を被覆する脂質類は、本発明が利用される産業分野において許容されるものであればよく、一般の食用油脂類又は工業用油脂類、脂肪酸グリセリド類、脂肪酸類、脂肪酸エステル類、脂肪酸アミド類、高級アルコール類、ワックス類、ステロール類、糖脂質類、リン脂質類等を単独で又は組合せて利用できる。これらのうち、被覆作業性及び被覆物の物性(安定性、固化性、流動性、溶融性、溶解性等)を考慮すると、融点が約30℃以上の脂質類がよい。より好ましい形態は融点が約40℃〜約70℃の脂質類であり、更に好ましい形態は融点が約40℃〜約60℃の脂質類である。融点が約30℃を下回ると、被覆物がその使用時に固形状態を維持できない場合があり、塊状物を形成することがあり、あるいは流動性を損なう場合がある。逆に、約70℃を上回ると、本発明に係る組成物を製造する際の加熱処理や機械的エネルギーの影響でチオクト酸類自体が劣化するおそれがある。The lipids that coat the outer surface of the thioctic acid crystals, powder, and / or particles may be acceptable as long as they are acceptable in the industrial field in which the present invention is used, such as general edible oils or industrial fats and oils, Fatty acid glycerides, fatty acids, fatty acid esters, fatty acid amides, higher alcohols, waxes, sterols, glycolipids, phospholipids and the like can be used alone or in combination. Of these, lipids having a melting point of about 30 ° C. or higher are preferable in consideration of coating workability and physical properties of the coating (stability, solidification, fluidity, meltability, solubility, etc.). More preferred forms are lipids having a melting point of about 40 ° C. to about 70 ° C., and still more preferred forms are lipids having a melting point of about 40 ° C. to about 60 ° C. When the melting point is less than about 30 ° C., the coating may not be able to maintain a solid state during use, and may form a lump or impair flowability. On the other hand, when the temperature exceeds about 70 ° C., the thioctic acids themselves may be deteriorated due to the influence of heat treatment and mechanical energy when producing the composition according to the present invention.

このような脂質類の具体例として、大豆油、菜種油、コーン油、ヒマワリ油、綿実油、小麦胚芽油、米油、ゴマ油、オリーブ油、サフラワー油、パーム油、パーム核油、ヤシ油、亜麻仁油、落花生油等の植物系油脂、牛脂、ラード、魚油等の動物系油脂、これらに分別、エステル交換、脱色、脱臭等の処理のうち1以上を施した加工油脂、これらを部分的又は完全に水素添加処理した各種硬化油、炭素数2〜22の飽和脂肪酸(酢酸、酪酸、カプロン酸、カプリル酸、カプリン酸、ラウリン酸、ミリスチン酸、ペンタデカン酸、パルミチン酸、ステアリン酸、12−ヒドロキシステアリン酸、イソステアリン酸、アラキジン酸、ベヘン酸等)若しくは不飽和脂肪酸(パルミトレイン酸、オレイン酸、エライジン酸、リノール酸、α−リノレン酸、γ−リノレン酸、リシノール酸、アラキドン酸、イコサペンタエン酸(EPA)、エルカ酸、ドコサヘキサエン酸(DHA)等)、これらの任意の脂肪酸の塩類(ナトリウム塩、カリウム塩、カルシウム塩、マグネシウム塩等)、1価アルコール(メタノール、エタノール、プロパノール、ブタノール等)とのエステル類、多価アルコール(エチレングリコール、プロピレングリコール、プタンジオール、ネオペンチルグリコール、グリセリン、エリスリトール等のモノマーないしポリマー)との部分若しくは完全エステル類、又はグリセリド類(モノグリセリド、ジグリセリド、トリグリセリド)、炭素数10〜22の高級アルコール類(デカノール、ラウリルアルコール、ミリスチルアルコール、セタノール、ステアリルアルコール、イソステアリルアルコール、ベヘニルアルコール等)、ワックス類(カルナウバワックス、ライスワックス(米糠ロウ)、キャンデリラワックス等の植物由来ワックス、ミツロウ、鯨ロウ、セラックロウ等の動物由来ワックス、パラフィンワックス、マイクロクリスタリンワックス等の石油由来ワックス、モンタンロウ、オゾケライト等の鉱物由来ワックス、ポリエチレンワックス、前記脂肪酸類と前記高級アルコール類とのエステル等の合成ワックス)、ステロール類(動物性のコレステロール、植物性のカンペステロール、スチグマステロール、シトステロール等、菌類由来のエルゴステロール、これらの誘導体)、リン脂質類(動植物由来のレシチン、ホスファチジルコリン、ホスファチジルエタノールアミン、ホスファチジルイノシトール、ホスファチジルセリン、ホスファチジン酸、スフィンゴミエリン等)、糖脂質類(モノグルコシルジグリセリド、モノガラクトシルジグリセリド、ジグルコシルモノグリセリド、ジガラクトシルモノグリセリド、モノグルコシルジグリセリド、ジガラクトシルジグリセリド、ショ糖脂肪酸エステル等)を挙げることができる。尚、本発明はこれらの例示によって何ら限定されるものではない。Specific examples of such lipids include soybean oil, rapeseed oil, corn oil, sunflower oil, cottonseed oil, wheat germ oil, rice oil, sesame oil, olive oil, safflower oil, palm oil, palm kernel oil, coconut oil, linseed oil , Vegetable oils such as peanut oil, animal fats such as beef tallow, lard, fish oil, processed oils and fats that have been subjected to one or more of such treatments as fractionation, transesterification, decolorization, deodorization, etc., partially or completely Various hydrogenated hydrogenated oils, saturated fatty acids having 2 to 22 carbon atoms (acetic acid, butyric acid, caproic acid, caprylic acid, capric acid, lauric acid, myristic acid, pentadecanoic acid, palmitic acid, stearic acid, 12-hydroxystearic acid , Isostearic acid, arachidic acid, behenic acid, etc.) or unsaturated fatty acids (palmitoleic acid, oleic acid, elaidic acid, linoleic acid, α-linolenic acid) , Γ-linolenic acid, ricinoleic acid, arachidonic acid, icosapentaenoic acid (EPA), erucic acid, docosahexaenoic acid (DHA), etc., salts of these arbitrary fatty acids (sodium salt, potassium salt, calcium salt, magnesium salt, etc.) Partially or completely with esters with monohydric alcohols (methanol, ethanol, propanol, butanol, etc.), polyhydric alcohols (monomers or polymers with ethylene glycol, propylene glycol, butanediol, neopentyl glycol, glycerin, erythritol, etc.) Esters or glycerides (monoglyceride, diglyceride, triglyceride), higher alcohols having 10 to 22 carbon atoms (decanol, lauryl alcohol, myristyl alcohol, cetanol, stearyl alcohol, Sostearyl alcohol, behenyl alcohol, etc.), waxes (carnauba wax, rice wax (rice bran wax), candelilla wax and other plant-derived waxes, beeswax, whale wax, shellac wax and other animal-derived waxes, paraffin wax, microcrystalline wax, etc. Oil-derived wax, wax derived from minerals such as montan wax, ozokerite, polyethylene wax, synthetic waxes such as esters of the above fatty acids and higher alcohols, sterols (animal cholesterol, plant campesterol, stigma) Ergosterols derived from fungi such as sterol and sitosterol, and derivatives thereof, phospholipids (lecithin derived from animals and plants, phosphatidylcholine, phosphatidylethanolamine, phosphatidylinos , Phosphatidylserine, phosphatidic acid, sphingomyelin, etc.), glycolipids (monoglucosyl diglyceride, monogalactosyl diglyceride, diglucosyl monoglyceride, digalactosyl monoglyceride, monoglucosyl diglyceride, digalactosyl diglyceride, sucrose fatty acid ester, etc.) be able to. In addition, this invention is not limited at all by these illustrations.

本発明では前記各種脂質類のいずれか1種又は2種以上の混合物として使用できるが、好適な脂質類の種類は、前記の食用油脂類又は工業用油脂類、脂肪酸グリセリド類、脂肪酸エステル類及びワックス類であり、より好ましくは食用油脂類及び脂肪酸グリセリド類であり、又、これらと脂肪酸類、高級アルコール類、ステロール類、糖脂質類又はリン脂質類から選ばれる1種又は2種以上との組み合わせは被覆脂質の融点調整、被覆膜強化等の点からさらに望ましい態様である。In the present invention, any one or a mixture of two or more of the above-mentioned various lipids can be used. Suitable types of lipids include the above edible oils or industrial fats, fatty acid glycerides, fatty acid esters and Waxes, more preferably edible fats and oils and fatty acid glycerides, and these and one or more selected from fatty acids, higher alcohols, sterols, glycolipids or phospholipids The combination is a more desirable embodiment from the viewpoint of adjusting the melting point of the coated lipid, reinforcing the coating film, and the like.

チオクト酸類の結晶、粉末及び/又は粒子の外表面を脂質類で被膜するには、公知の方法を利用できる。すなわち、ボールミル、フラッシュブレンダー(粉粒体混合機)、V型混合機、高速ミキサー、高速パドルミキサー、加熱溶融混合機、超音波過湿加液型混合機、タンブラー混合機、加圧押出機等を用い、チオクト酸類の結晶、粉末及び/又は粒子と加熱溶融した脂質類とを均一に混合し、冷却して固化させた後これを粉砕する方法、前記形態のチオクト酸類に適宜加熱して液状化した脂質類を噴霧あるいは滴下して被覆する方法、前記形態のチオクト酸類と粒子状の脂質類とを高速攪拌して混合し、両者を接触又は衝突させることによってチオクト酸類の結晶、粉末及び/又は粒子の表面全体に粒子状の脂質類を均一に付着させて被覆する方法等が可能である。本発明では、これらのうち、チオクト酸類の結晶、粉末及び/又は粒子と前述の特定融点以上の粒子状脂質類とを高速攪拌して混合し、両者を接触又は衝突させて、前記形態のチオクト酸類の表面全体に粒子状の脂質類を均一に被覆させる方法が望ましい。A known method can be used to coat the outer surface of the thioctic acid crystals, powder and / or particles with lipids. That is, ball mill, flash blender (powder granule mixer), V-type mixer, high-speed mixer, high-speed paddle mixer, heat-melt mixer, ultrasonic super-humidified liquid-type mixer, tumbler mixer, pressure extruder, etc. The thioctic acid crystals, powder and / or particles and the heated and melted lipids are uniformly mixed, cooled and solidified, and then pulverized. A method of coating by spraying or dripping the lipids which have been formed, and stirring and mixing the thioctic acids of the above-mentioned form and particulate lipids at high speed, and bringing them into contact or colliding with each other, thereby producing crystals, powders and / or thioctic acids. Alternatively, a method in which particulate lipids are uniformly attached to the entire surface of the particle and coated is possible. In the present invention, among these, thioctic acid crystals, powders and / or particles and particulate lipids having a specific melting point or higher are mixed with high-speed stirring, and both are brought into contact with or collided with each other to obtain the thioctic acid of the above form. A method of uniformly coating particulate lipids on the entire surface of acids is desirable.

前述の被覆処理にあたり、チオクト酸類の結晶、粉末及び/又は粒子と脂質類との比率は、チオクト酸類の結晶、粉末及び粒子の形状やサイズ、脂質類の種類及び融点、被覆膜の厚みと性状等の要因によって一律に規定することは難しいが、概ね、チオクト酸類の結晶、粉末及び/又は粒子1重量部に対して脂質類約0.05重量部〜約10重量部、好ましくは約0.1重量部〜約5重量部である。脂質類が約0.05重量部未満であると被覆状態が十分でなく所望の効果を発現し難くなり、逆に約10重量部を超えると被覆物中のチオクト酸含量が少なく、被覆物を利用する場面において配合率等が制限され実用的価値を損なう場合がある。In the above-described coating treatment, the ratio of thioctic acid crystals, powders and / or particles to lipids, thioctic acid crystals, powder and particle shapes and sizes, lipid types and melting points, coating film thickness and Although it is difficult to define uniformly depending on factors such as properties, about 0.05 parts by weight to about 10 parts by weight, preferably about 0 parts by weight of lipids are generally added to 1 part by weight of crystals, powders and / or particles of thioctic acids. .1 part by weight to about 5 parts by weight. If the lipids are less than about 0.05 parts by weight, the coating state is not sufficient and it is difficult to achieve the desired effect. Conversely, if the lipids exceed about 10 parts by weight, the thioctic acid content in the coating is low, In the scene where it is used, the blending rate and the like are limited, and the practical value may be impaired.

なお、前述したチオクト酸類の脂質類による被覆物は、これを飲料等の水系組成物に適用する場合の有無にかかわらず、更にその外表面を親水系物質で被覆してなる態様のものがより一層望ましい。ここで、親水系物質とは、脂質類による被覆物の外表面を更に被覆し、水性物質と親和性を有する被覆膜形成能のあるものをいい、具体例として多糖類(キサンタンガム、グアーガム、タマリンドシードガム、サイリウムシードガム等)、澱粉及び化工澱粉、酵母細胞壁成分、グルカン、マンナン、シェラック、アルギン酸ソーダ、ゼラチン、カラギーナン、プルラン、カルボキシメチルセルロース、大豆たん白、ホエーたん白、ツェイン等を挙げることができる。より好適には多糖類、澱粉、酵母細胞壁成分、シェラック、ゼラチン、大豆たん白、ツェイン及びマンナンからなる群から選ばれる1種又は2種以上であり、更に好ましくは酵母細胞壁成分、シェラック及びゼラチンである。The above-described coating of thioctic acids with lipids is more preferably an embodiment in which the outer surface is further coated with a hydrophilic substance regardless of whether or not this is applied to an aqueous composition such as a beverage. More desirable. Here, the hydrophilic substance means a substance that further coats the outer surface of the coating with lipids and has a coating film-forming ability having an affinity with an aqueous substance. Specific examples include polysaccharides (xanthan gum, guar gum, Tamarind seed gum, psyllium seed gum), starch and modified starch, yeast cell wall components, glucan, mannan, shellac, sodium alginate, gelatin, carrageenan, pullulan, carboxymethylcellulose, soy protein, whey protein, zein, etc. Can do. More preferably, it is one or more selected from the group consisting of polysaccharides, starch, yeast cell wall components, shellac, gelatin, soybean protein, zein and mannan, and more preferably yeast cell wall components, shellac and gelatin. is there.

かかる親水系物質を被覆するには、前記の脂質類の被覆方法に準じた方法を採用すればよい。すなわち、前記親水系物質を適宜に水、エタノール、その他の溶媒に溶解させた液状物となし、これを予め脂質類で被覆したチオクト酸類の外表面に付着、乾燥して親水系物質の被覆膜を形成させることができる。かかる被覆物は親水系物質を最外層とする二重被覆構造体となり、これを飲食品、飼料、化粧品、医薬品等に利用する場合、水性の原料や成分との親和性が高まり、これらと水溶解性の低いチオクト酸類との均質な組成物を調製することが容易になる。In order to coat such a hydrophilic substance, a method according to the above-described method for coating lipids may be employed. That is, the hydrophilic substance is appropriately dissolved in water, ethanol, or other solvent to form a liquid, and this is attached to the outer surface of thioctic acid previously coated with lipids and dried to coat the hydrophilic substance. A film can be formed. Such a coating becomes a double-coated structure having a hydrophilic substance as the outermost layer, and when this is used for foods, drinks, feeds, cosmetics, pharmaceuticals, etc., the affinity with aqueous raw materials and ingredients increases, It becomes easy to prepare a homogeneous composition with thioctic acids having low solubility.

前述したようなチオクト酸類の脂質類による被覆物及び該被覆物を更に親水系物質で被覆した二重被覆物においては、これらにガルシニア・カンボジア果皮、アカショウマ根茎、グアバ葉及びこれらの抽出物(水及び/又は親水性有機溶媒(エタノール等の低級1価アルコール、アセトン等)による抽出エキス、その分画物や溶剤分別物又は精製物等)、カルニチンからなる群から選択される1種又は2種以上、より好ましくはアカショウマ根茎抽出物及びカルニチン、最も好ましくはカルニチン、を共存させることにより、チオクト酸類の熱的及び/又は酸化的変性や劣化をより一層抑制でき安定性に優れたチオクト酸類含有被覆物が得られるため、かかる態様のチオクト酸類は本発明において更に望ましい。In the above-described coating of thioctic acids with lipids and the double coating in which the coating is further coated with a hydrophilic substance, these include Garcinia camphor peel, red pepper rhizome, guava leaf and extracts thereof (water And / or one or two selected from the group consisting of an extract with a hydrophilic organic solvent (e.g., a lower monohydric alcohol such as ethanol, acetone, its fraction, a solvent fraction or a purified product), and carnitine. As described above, a thioctic acid-containing coating that can further suppress thermal and / or oxidative denaturation and degradation of thioctic acids by coexistence with red pepper rhizome extract and carnitine, most preferably carnitine, and has excellent stability. The thioctic acids of this embodiment are more desirable in the present invention since a product is obtained.

これらの併用原料を、前述のチオクト酸類含有被覆物に含有せしめる態様は、(i)チオクト酸類の結晶、粉末及び/又は粒子に脂質類を被覆した被覆物に前記併用原料を混合する、(ii)チオクト酸類の結晶、粉末及び/又は粒子と前記併用原料とを混合したものに脂質類を被覆する、(iii)チオクト酸類の結晶、粉末及び/又は粒子に、前記併用原料の一部を分散ないし溶解させた脂質類を被覆する、(iv)チオクト酸類の結晶、粉末及び/又は粒子に脂質類を被覆した被覆物に、前記併用原料及び前記親水系物質を含む溶解液、分散液又は乳化液を付着、乾燥して被覆する、のいずれも可能であり、これらの態様を組み合せたものでも差し支えない。本発明では、(i)及び(iv)の態様が本発明の所望効果を奏し、製造が簡便であり、被覆物の取扱い作業性もよいが、(ii)及び(iii)の態様が所望の効果をより強力に発現しやすい。In the embodiment in which these combined raw materials are contained in the above-mentioned thioctic acid-containing coating, (i) the combined raw material is mixed with a coating in which lipids are coated on thioctic acid crystals, powder and / or particles. ) A lipid is coated on a mixture of the thioctic acid crystals, powders and / or particles and the combination raw material. (Iii) A part of the combination raw material is dispersed in the thioctic acid crystals, powder and / or particles. Or (iv) a solution obtained by coating the lipids on the thioctic acid crystals, powder and / or particles, and a solution, dispersion or emulsification containing the combined raw material and the hydrophilic substance. Any of attaching and drying and coating the liquid is possible, and a combination of these embodiments may be used. In the present invention, the aspects (i) and (iv) have the desired effects of the present invention, the production is simple, and the handling workability of the coating is good, but the aspects (ii) and (iii) are desirable. It is easy to express the effect more powerfully.

かかる態様において、チオクト酸類の結晶、粉末及び/又は粒子に脂質類又は脂質類及び親水系物質を被覆した被覆物と前記併用原料との混合比率は、該被覆物1重量部に対して前記併用原料が約0.01重量部〜約10重量部、より好ましくは約0.1重量部〜約1重量部である。約0.01重量部未満の場合は、併用原料の混合による所望効果の向上が認められなくなり、約10重量部を超える量では前記被覆物中更にはこれを使用する組成物中のチオクト酸含量が低下し、ひいてはチオクト酸類含有組成物を配合する各種製品中のチオクト酸含量を制限することになり、該製品段階においてチオクト酸自体の所望効果が期待できなくなる。In such an embodiment, the mixing ratio of the coating material obtained by coating the crystals, powders and / or particles of thioctic acid with lipids or lipids and a hydrophilic substance and the combination raw material is the combined use with respect to 1 part by weight of the coating material. The raw material is about 0.01 parts by weight to about 10 parts by weight, more preferably about 0.1 parts by weight to about 1 part by weight. When the amount is less than about 0.01 part by weight, the desired effect cannot be improved by mixing the combined raw materials. When the amount exceeds about 10 parts by weight, the content of thioctic acid in the coating and further in the composition using the same As a result, the thioctic acid content in various products containing the thioctic acid-containing composition is limited, and the desired effect of thioctic acid itself cannot be expected in the product stage.

本発明に係る組成物において、キチン加水分解物は、キチンを酸及び酵素の少なくとも一方を用いて加水分解処理して得られるものであることが望ましく、更にはN−アセチルキトオリゴ糖及び/又はN−アセチルグルコサミンを主たる成分として含有するものがより好ましい。ここで、N−アセチルキトオリゴ糖は、その構成単位であるN−アセチルグルコサミンの二量体(N−アセチルキトビオース)ないし七量体(N−アセチルキトヘプタオース)程度を含有するものが望ましく、N−アセチルキトオリゴ糖及びN−アセチルグルコサミンの混合割合は任意でよいが、N−アセチルグルコサミンが多いほどよい。In the composition according to the present invention, the chitin hydrolyzate is preferably obtained by hydrolyzing chitin with at least one of an acid and an enzyme, and further, N-acetylchitooligosaccharide and / or What contains N-acetylglucosamine as a main component is more preferable. Here, the N-acetylchitooligosaccharide contains a dimer (N-acetylchitobiose) to a heptamer (N-acetylchitoheptaose) of N-acetylglucosamine which is a structural unit. Desirably, the mixing ratio of N-acetylchitooligosaccharide and N-acetylglucosamine may be arbitrary, but the more N-acetylglucosamine is, the better.

かかるキチン加水分解物は、前述のような公知の製造方法によって得られるものでよい。例えば、エビ、蟹等の甲殻を希塩酸処理してカルシウム分を除去し、次いで水酸化ナトリウム処理して蛋白質を除去してキチンを調製し、このキチンに濃塩酸を加えて30〜50℃で3〜6時間適宜に撹拌して加水分解物を含有する水溶液を得る。その後、適宜、該加水分解液にほぼ同量の冷水を添加し、更に20〜50%水酸化ナトリウム水溶液を加えて中和熱による液温上昇を防ぎながら中和処理、活性炭による脱色処理、透析膜による脱塩処理、イオン交換樹脂による脱アセチル化物除去処理等を施して精製し、乾燥処理を経て粉末状のキチン加水分解物を製造することができる。このキチン加水分解物はN−アセチルキトオリゴ糖及びN−アセチルグルコサミンを含み、精製度が低い場合は脱アセチル化物であるD−グルコサミン等を含有している。Such chitin hydrolyzate may be obtained by a known production method as described above. For example, shellfish such as shrimp and salmon are treated with dilute hydrochloric acid to remove calcium, and then treated with sodium hydroxide to remove protein to prepare chitin. Concentrated hydrochloric acid is added to this chitin and the mixture is heated at 30-50 ° C. for 3 minutes. Stir appropriately for -6 hours to obtain an aqueous solution containing the hydrolyzate. Thereafter, as appropriate, approximately the same amount of cold water is added to the hydrolyzed solution, and further 20 to 50% sodium hydroxide aqueous solution is added to prevent neutralization heat, neutralization treatment, decolorization treatment with activated carbon, dialysis A powdery chitin hydrolyzate can be produced through a desalting treatment using a membrane, a deacetylation product removing treatment using an ion exchange resin, etc., and purification, followed by a drying treatment. This chitin hydrolyzate contains N-acetylchitooligosaccharide and N-acetylglucosamine, and when the degree of purification is low, it contains D-glucosamine which is a deacetylated product.

又、前記のキチン加水分解物を水に溶解して5〜10%キチン加水分解物水溶液とし、キチナーゼ、キトビアーゼ、リゾチーム等の加水分解酵素を加え、30〜50℃で6〜48時間ゆるやかに撹拌して加水分解反応を行わせた後、酵素を加熱失活させ、適宜に前記精製処理を施してN−アセチルグルコサミンを主成分とするキチン加水分解物を製造することができる。尚、キチンを直接キチナーゼで処理するとN−アセチルグルコサミンの二量体(N−アセチルキトビオース)を主たる成分とするキチン加水分解物が得られる。Also, dissolve the chitin hydrolyzate in water to make 5-10% chitin hydrolyzate aqueous solution, add hydrolase such as chitinase, chitobiase, lysozyme, etc. and gently stir at 30-50 ° C. for 6-48 hours Then, after the hydrolysis reaction is performed, the enzyme is heated and deactivated, and the purification treatment is appropriately performed to produce a chitin hydrolyzate containing N-acetylglucosamine as a main component. In addition, when chitin is directly treated with chitinase, a chitin hydrolyzate containing N-acetylglucosamine dimer (N-acetylchitobiose) as a main component is obtained.

本発明に係る組成物は、前述したチオクト酸類及びキチン加水分解物のいずれか一方又は両方を必須原料としてなるものであり、これらを併用することがより望ましい態様である。この場合、チオクト酸類:キチン加水分解物=80〜20:20〜80(重量比)がより好ましく、70〜50:30〜50が最も好ましい。尚、本発明に係る組成物はチオクト酸類とキチン加水分解物とを同一組成物中に含有せしめる態様のほかに、各々を含有する別異の組成物をほぼ同時に摂取したり、生体にとり込む態様でもよい。かかる組成物は、これ自体を飲食品、医薬品、化粧品、その他産業分野の様々な製品とすることができ、あるいは該各種製品の配合原料の一部として使用する態様でも利用できる。とりわけ飲食品用途が好適である。これらの例を以下に述べるが、本発明はこれによって何ら制限を受けるものではない。The composition according to the present invention comprises one or both of the above-described thioctic acids and chitin hydrolyzate as an essential raw material, and it is a more desirable embodiment to use these in combination. In this case, thioctic acids: chitin hydrolyzate = 80 to 20:20 to 80 (weight ratio) is more preferable, and 70 to 50:30 to 50 is most preferable. The composition according to the present invention is a mode in which thioctic acids and chitin hydrolyzate are contained in the same composition, and different compositions containing each are ingested or taken into the living body almost simultaneously. But you can. Such a composition itself can be used as a variety of products in food and drink, pharmaceuticals, cosmetics, and other industrial fields, or can be used in a form of being used as a part of a blended raw material of the various products. In particular, food and drink applications are suitable. Examples of these are described below, but the present invention is not limited thereby.

飲食品の具体例として、野菜ジュース、果汁飲料、清涼飲料、茶等の飲料類、スープ、ゼリー、プリン、ヨーグルト、ケーキプレミックス製品、菓子類、ふりかけ、味噌、醤油、ソース、ドレッシング、マヨネーズ、植物性クリーム、味噌、焼肉用たれや麺つゆ等の調味料、麺類、うどん、蕎麦、スパゲッティ、ハムやソーセージ等の畜肉魚肉加工食品、ハンバーグ、コロッケ、ふりかけ、佃煮、ジャム、牛乳、クリーム、バター、スプレッドやチーズ等の粉末状、固形状又は液状の乳製品、マーガリン、パン、ケーキ、クッキー、チョコレート、キャンディー、グミ、ガム等の各種一般加工食品のほか、粉末状、顆粒状、丸剤状、錠剤状、ソフトカプセル状、ハードカプセル状、ペースト状又は液体状の栄養補助食品、特定保健用食品、機能性食品、健康食品、濃厚流動食や嚥下障害用食品の治療食等を挙げることができる。Specific examples of food and drink include beverages such as vegetable juice, fruit juice drinks, soft drinks, tea, soup, jelly, pudding, yogurt, cake premix products, confectionery, sprinkles, miso, soy sauce, sauce, dressing, mayonnaise, Vegetable cream, miso, seasonings such as grilled meat sauce and noodle soup, noodles, udon, soba noodles, spaghetti, ham and sausage, etc. , Powders such as spreads and cheese, solid or liquid dairy products, margarine, bread, cakes, cookies, chocolates, candy, gummi, gums, and other general processed foods, powders, granules, pills , Tablets, soft capsules, hard capsules, pasty or liquid dietary supplements, food for specified health use, machine Sex food, mention may be made of health food products, the concentrated liquid diet and dysphagia for food diet and the like.

これらの飲食品を製造するには、公知の原材料及び本発明の組成物を用い、あるいは公知の原材料の一部を本発明の組成物で置き換え、公知の方法によって製造すればよい。例えば、本発明の組成物と、必要に応じてグルコース(ブドウ糖)、デキストリン、乳糖、澱粉又はその加工物、セルロース粉末等の賦形剤、ビタミン、ミネラル、動植物や魚介類の油脂、たん白(動植物や酵母由来の蛋白質、その加水分解物等)、糖質、色素、香料、酸化防止剤、その他の食用添加物、各種栄養機能成分を含む粉末やエキス類等の食用素材とともに混合して粉末、顆粒、ペレット、錠剤等の形状に加工したり、常法により前記例の一般食品に加工処理したり、これらを混合した液状物をゼラチン、アルギン酸ナトリウム、カルボキシメチルセルロース等で被覆してカプセルを成形したり、飲料(ドリンク類)の形態に加工して、栄養補助食品や健康食品として利用することは好適である。とりわけ錠剤、カプセル剤やドリンク剤が望ましい。In order to produce these foods and drinks, a known raw material and the composition of the present invention may be used, or a part of the known raw material may be replaced with the composition of the present invention and produced by a known method. For example, the composition of the present invention and, if necessary, glucose (dextrose), dextrin, lactose, starch or processed product thereof, excipients such as cellulose powder, vitamins, minerals, fats and oils of animals and plants and seafood, protein ( Animal, plant and yeast-derived proteins, hydrolysates thereof, etc.), carbohydrates, pigments, fragrances, antioxidants, other edible additives, powders containing various nutritional functional ingredients, and edible ingredients such as extracts, mixed into powder , Processed into the shape of granules, pellets, tablets, etc., processed into the general foods of the above examples by conventional methods, or coated with gelatin, sodium alginate, carboxymethylcellulose, etc. to form a capsule Or processed into a beverage (drinks) form and used as a dietary supplement or health food. In particular, tablets, capsules and drinks are desirable.

かかる飲食品に配合する本発明の組成物の比率は、飲食品の形態、本発明の組成物中のチオクト酸類やキチン加水分解物の含量、他の配合原料の種類や成分等のちがいにより一律に規定しがたいが、飲食品中のチオクト酸含量が約0.01重量%〜約90重量%、より望ましくは約1重量%〜約50重量%となるように、チオクト酸類、その脂質被覆物及び/又は二重被覆物を、更にはガルシニア・カンボジア果皮、アカショウマ根茎、グアバ葉、これらの抽出物及びカルニチンから適宜選ばれる併用原料、及びその他の飲食品製造用原料を適宜に組み合わせて処方を設計し、常法に従い目的とする飲食品を調製すればよい。チオクト酸含量が約0.01重量%を下回るような飲食品ではチオクト酸類による所望効果を期待するためには多量の当該飲食品を摂取しなければならず、一方、約90重量%が本発明の飲食品中の最大チオクト酸含量である。本発明の飲食品は、ヒトの場合1日あたりのチオクト酸摂取量の目安を約10mg〜約1000mg、望ましくは約30mg〜約500mg、さらに望ましくは約50mg〜約200mgとして任意の方法、例えば、経口摂取、経管投与等の方法で体内に取り込むことができる。The ratio of the composition of the present invention to be blended in such food and drink is uniform depending on the form of the food and drink, the content of thioctic acids and chitin hydrolyzate in the composition of the present invention, and the types and ingredients of other blended raw materials. However, the thioctic acid and its lipid coating may be used so that the thioctic acid content in the food and drink is about 0.01% to about 90% by weight, more preferably about 1% to about 50% by weight. And / or double coatings, combined with Garcinia cambodia peel, red pepper rhizome, guava leaf, combination ingredients appropriately selected from these extracts and carnitine, and other food and beverage production ingredients And the desired food or drink may be prepared according to conventional methods. In foods and beverages having a thioctic acid content of less than about 0.01% by weight, in order to expect the desired effect of thioctic acids, a large amount of the foods and beverages must be ingested, while about 90% by weight is present in the present invention. The maximum thioctic acid content in foods and beverages. In the case of humans, the food and drink of the present invention can be used in any method, for example, by setting a daily thioctic acid intake standard of about 10 mg to about 1000 mg, preferably about 30 mg to about 500 mg, more preferably about 50 mg to about 200 mg. It can be taken into the body by methods such as oral intake and tube administration.

次に、実施例を挙げて本発明を詳細に説明するが、本発明はこれによって限定されるものではない。各例において、%、部及び比率はいずれも重量基準である。Next, although an Example is given and this invention is demonstrated in detail, this invention is not limited by this. In each example, all the percentages, parts and ratios are based on weight.

(製造例1)
(1)チオクト酸の脂質被覆物
結晶粉末のチオクト酸(ドイツ・デグサ社製、商品名:ALIPURE(登録商標)、ラセミ体)300gに加熱溶融したナタネ硬化油(川研ファインケミカル(株)製、融点:67℃、フレーク状)200gを加え、よく混合して均一に分散させた後、室温に冷却固化させた。次いで、該固化物を高速ミキサーで粉砕し、100メッシュ(タイラーメッシュ。以下同じ)で篩過して粒子径150μm以下のチオクト酸脂質被覆物(試料1)を得た。
(Production Example 1)
(1) Thioctic acid lipid coating Crystal powder of thioctic acid (manufactured by Degussa, Germany, trade name: ALIPURE (registered trademark), racemic body) heat-melted rapeseed oil (manufactured by Kawaken Fine Chemical Co., Ltd.) (Melting point: 67 ° C., flake shape) 200 g was added, mixed well and dispersed uniformly, and then cooled and solidified to room temperature. Next, the solidified product was pulverized with a high-speed mixer, and sieved with 100 mesh (Tyler mesh; the same applies hereinafter) to obtain a thioctic acid lipid coating (sample 1) having a particle size of 150 μm or less.

前記チオクト酸200gと粉末状ナタネ硬化油(川研ファインケミカル(株)製、融点:60℃、平均粒子径が約20μm)200gとを微粒子コーティング造粒装置((株)パウレック製、型式:MP−25SFP)に仕込み、攪拌混合ファンブレードの回転数1000rpmで30分間流動、混合して前記両原料を接触、衝突させて平均粒径が約100μmのチオクト酸脂質被覆物(試料2)を得た。200 g of the thioctic acid and 200 g of powdered rapeseed oil (manufactured by Kawaken Fine Chemicals Co., Ltd., melting point: 60 ° C., average particle diameter of about 20 μm) are coated with a fine particle coating granulator (manufactured by POWREC Co., Ltd., model: MP- 25SFP), and the mixture was flowed and mixed for 30 minutes at a rotation speed of a stirring and mixing fan blade of 1000 rpm, and the two raw materials were brought into contact with each other and collided to obtain a thioctic acid lipid coating (sample 2) having an average particle diameter of about 100 μm.

前記チオクト酸脂質被覆物(試料2)の製造例において、チオクト酸200gをチオクト酸150g及びグアバ葉エキス(ビーエイチエヌ(株)製、商品名:グアバ葉エキス末−S)50gの混合物に置きかえたこと以外は同様にして処理し、チオクト酸脂質被覆物(試料3)を得た。In the production example of the thioctic acid lipid coating (sample 2), 200 g of thioctic acid was replaced with a mixture of 150 g of thioctic acid and 50 g of guava leaf extract (manufactured by BN Co., Ltd., trade name: guava leaf extract powder-S). In the same manner as above, a thioctic acid lipid coating (sample 3) was obtained.

前記チオクト酸脂質被覆物(試料2)の製造例において、コーティング造粒装置にチオクト酸200gを仕込み、攪拌流動させながら、大豆油:40部、カルナウバワックス:40部及び大豆ステロール:20部からなる脂質混合物100g、L−カルニチン−L−酒石酸塩(ロンザジャパン(株)製)30g、及びショ糖ベヘン酸エステル(三菱化学フーズ(株)製、リョートー(登録商標)シュガーエステル、HLB:1〜2)20gを70℃に加熱、溶融、混合した均質液状物をスプレーノズルから噴出させてチオクト酸表面を被覆し、チオクト酸脂質被覆物(試料4)を得た。In the production example of the thioctic acid lipid coating (sample 2), 200 g of thioctic acid was charged into a coating granulator and stirred and flowed, soybean oil: 40 parts, carnauba wax: 40 parts and soy sterol: 20 parts Lipid mixture 100 g, L-carnitine-L-tartrate (Lonza Japan, Inc.) 30 g, and sucrose behenate (Mitsubishi Chemical Foods, Ryoto (registered trademark) sugar ester, HLB: 1 2) A homogeneous liquid material obtained by heating, melting and mixing 20 g at 70 ° C. was ejected from a spray nozzle to coat the surface of thioctic acid to obtain a thioctic acid lipid coating (sample 4).

(製造例2)
(2)チオクト酸の二重被覆物
前記のチオクト酸脂質被覆物(試料1、試料3)のいずれかの一部を前記チオクト酸脂質被覆物(試料2)の製造例で使用したコーティング造粒装置(但し、同社製、型式:MP−01SFP)に仕込み、攪拌流動させながら、酵母細胞壁8.0%を含む分散液(キリンビール(株)製、商品名:イーストラップ(登録商標))を噴霧させて各チオクト酸脂質被覆物粒子の表面を親水系物質で被覆し、チオクト酸二重被覆物(試料5、試料7)を得た。又、前記のチオクト酸脂質被覆物(試料2、試料4)について、酵母細胞壁8.0%含有分散液をシェラック20%含有含水エタノール液に置きかえることを除いて同様に処理し、チオクト酸二重被覆物(試料6、試料8)を得た。
(Production Example 2)
(2) Double coating of thioctic acid Coating granulation using a part of any of the above thioctic acid lipid coatings (sample 1, sample 3) in the production example of the thioctic acid lipid coating (sample 2) A dispersion (made by Kirin Brewery Co., Ltd., trade name: East Wrap (registered trademark)) containing 8.0% yeast cell wall is charged into an apparatus (provided by the company, model: MP-01SFP), and stirred and flowed. Spraying was performed to coat the surface of each thioctic acid lipid-coated particle with a hydrophilic substance to obtain a thioctic acid double coating (Sample 5, Sample 7). In addition, the thioctic acid lipid coating (sample 2 and sample 4) was treated in the same manner except that the dispersion containing 8.0% yeast cell wall was replaced with an aqueous ethanol solution containing 20% shellac. Coatings (Sample 6, Sample 8) were obtained.

(製造例3)
(3)キチン加水分解物
キチン加水分解物を以下の方法で作成した。すなわち、エビと蟹の各甲殻皮の混合物を希塩酸で脱カルシウム処理、水酸化ナトリウムで脱蛋白処理した後、乾燥及び粉砕してキチンを調製した。該キチン1kgに濃塩酸4リットルを加え、35〜40℃で適宜撹拌しながら加水分解を行った後、同容量の水を加えて希釈し、同温度にて20%水酸化ナトリウム水溶液で中和した。次いで、この中和液に活性炭250gを加えて脱色し、不溶物を濾別して無色透明の濾液を得た。該濾液を常法により透析膜処理して脱塩液を得た後、これを陽イオン交換樹脂(三菱化学(株)製、商品名:ダイヤイオン(登録商標)SK1B)充填カラム及び陰イオン交換樹脂(三菱化学(株)製、商品名:ダイヤイオン(登録商標)SA10A)充填カラムに通して脱色、精製を行い、濃縮、噴霧乾燥して白色粉末450gを得た。この粉末の組成は、高速液体クロマトグラフィーによる分析の結果、N−アセチル−D−グルコサミン28%、N−アセチルキトビオース17%、N−アセチルキトトリオース19%、N−アセチルキトテトラオース16%、N−アセチルキトペンタオース10%、N−アセチルキトヘキサオース7%、N−アセチルキトヘプタオース2%、その他1%であった(N−アセチルキトオリゴ糖及びN−アセチル−D−グルコサミンの混合物:試料9)。
(Production Example 3)
(3) Chitin hydrolyzate A chitin hydrolyzate was prepared by the following method. That is, a mixture of shrimp and salmon shells was decalcified with dilute hydrochloric acid and deproteinized with sodium hydroxide, and then dried and ground to prepare chitin. Add 4 liters of concentrated hydrochloric acid to 1 kg of the chitin, hydrolyze with stirring at 35-40 ° C., dilute by adding the same volume of water, and neutralize with 20% aqueous sodium hydroxide at the same temperature. did. Next, 250 g of activated carbon was added to the neutralized solution for decolorization, and insoluble matters were filtered off to obtain a colorless transparent filtrate. The filtrate was subjected to a dialysis membrane treatment by a conventional method to obtain a desalted solution, which was then packed into a cation exchange resin (manufactured by Mitsubishi Chemical Corporation, trade name: Diaion (registered trademark) SK1B) and anion exchange. The resin (Mitsubishi Chemical Co., Ltd., trade name: Diaion (registered trademark) SA10A) was passed through a packed column for decolorization and purification, followed by concentration and spray drying to obtain 450 g of a white powder. The composition of this powder was analyzed by high performance liquid chromatography. As a result, N-acetyl-D-glucosamine 28%, N-acetylchitobiose 17%, N-acetylchitotriose 19%, N-acetylchitotetraose 16 %, N-acetylchitopentaose 10%, N-acetylchitohexaose 7%, N-acetylchitoheptaose 2%, and others 1% (N-acetylchitooligosaccharide and N-acetyl-D-glucosamine Mixture of: Sample 9).

又、前記白色粉末50gを水1リットルに溶解させ、キチナーゼ(シグマ社製、セラチア・マルセッセンス由来)750単位を加え、40℃でゆるやかにかき混ぜながら48時間酵素を作用させた後、95℃の熱湯浴中で10分間加熱して酵素を失活させた。次いで、不溶物を濾別し、濾液を活性炭/セライト(1/1)充填カラムに通して脱色及び未分解のN−アセチルキトオリゴ糖を除去して精製し、さらに濃縮、乾燥して白色粉末34gを得た。これは、高速液体クロマトグラフィー分析の結果、N−アセチル−D−グルコサミンの純品であった(N−アセチル−D−グルコサミン:試料10)。Further, 50 g of the above white powder was dissolved in 1 liter of water, 750 units of chitinase (manufactured by Sigma, Serratia marcescens) was added, the enzyme was allowed to act for 48 hours while gently stirring at 40 ° C., and then hot water at 95 ° C. The enzyme was inactivated by heating in a bath for 10 minutes. The insoluble matter is then filtered off, and the filtrate is passed through a column packed with activated carbon / Celite (1/1) to remove decolorized and undegraded N-acetylchitooligosaccharide and purified, followed by concentration and drying to obtain a white powder. 34 g was obtained. This was a pure product of N-acetyl-D-glucosamine as a result of high performance liquid chromatography analysis (N-acetyl-D-glucosamine: sample 10).

(試験例)
本発明の組成物に係る成分が紫外線照射による皮膚障害(伸張、肥厚及び炎症)の改善、予防に及ぼす影響を以下に述べる方法で調べた。すなわち、本発明に係る組成物である試験物質は、(1)チオクト酸、(2)チオクト酸脂質被覆物、(3)チオクト酸二重被覆物、(4)N−アセチル−D−グルコサミン、(5)N−アセチルキトオリゴ糖及びN−アセチル−D−グルコサミンの混合物、(6)チオクト酸とN−アセチル−D−グルコサミンとの混合物(1:1)、(7)チオクト酸とN−アセチルキトオリゴ糖及びN−アセチル−D−グルコサミンの混合物との混合物(2:1)、(8)チオクト酸脂質被覆物とN−アセチルキトオリゴ糖及びN−アセチル−D−グルコサミン混合物との混合物(1:1)、及び(9)チオクト酸二重被覆物とN−アセチル−D−グルコサミンとの混合物(3:1)とした。ここに、チオクト酸はドイツ・デグサ社製、商品名:ALIPURE(登録商標)、チオクト酸脂質被覆物は試料1〜試料4、チオクト酸二重被覆物は試料5〜試料8、N−アセチル−D−グルコサミンは試料10、N−アセチルキトオリゴ糖及びN−アセチル−D−グルコサミンの混合物は試料9である。
(Test example)
The effects of the components of the composition of the present invention on the improvement and prevention of skin damage (stretching, thickening and inflammation) caused by ultraviolet irradiation were examined by the method described below. That is, the test substance which is the composition according to the present invention includes (1) thioctic acid, (2) thioctic acid lipid coating, (3) thioctic acid double coating, (4) N-acetyl-D-glucosamine, (5) a mixture of N-acetylchitooligosaccharide and N-acetyl-D-glucosamine, (6) a mixture of thioctic acid and N-acetyl-D-glucosamine (1: 1), (7) thioctic acid and N- Mixture of acetylchitooligosaccharide and N-acetyl-D-glucosamine mixture (2: 1), (8) Mixture of thioctic acid lipid coating and N-acetylchitooligosaccharide and N-acetyl-D-glucosamine mixture (1: 1) and (9) A mixture (3: 1) of thioctic acid double coating and N-acetyl-D-glucosamine. Here, thioctic acid is manufactured by Degussa, Germany, trade name: ALIPURE (registered trademark), thioctic acid lipid coating is sample 1 to sample 4, thioctic acid double coating is sample 5 to sample 8, N-acetyl- D-glucosamine is sample 10, and a mixture of N-acetylchitooligosaccharide and N-acetyl-D-glucosamine is sample 9.

C57BL/6J雄性マウス(5週齢)(日本SLC(株)製)を1週間予備飼育後、1群8匹とし、正常群、紫外線照射群(コントロール群)及び試験物質投与群に分けた(試験物質投与群は各投与群につき8匹ずつ)。試験期間中、飼料及び水は自由摂取させた。前記マウスの背部を脱毛処理し、2日後から正常群及びコントロール群には蒸留水を、試験物質投与群には蒸留水で懸濁した前記試験物質溶液を、それぞれ胃ゾンデを用いて1日2回2週間、マウス体重10gあたり0.1mLを強制経口投与した。試験物質の投与量は、チオクト酸、チオクト酸脂質被覆物及びチオクト酸二重被覆物は各50mg/kg体重×2回/日、N−アセチル−D−グルコサミン、N−アセチルキトオリゴ糖及びN−アセチル−D−グルコサミンの混合物は各500mg/kg体重とした。紫外線照射はUVBランプ(家田貿易(株)製、型式:T−15M、15Wタイプ、UV波長:312nm、UV強度:1,000μW/cm)をマウス背部から50cm離して、脱毛処理した4日後から5日間、1日20分間照射し、それ以降は同条件で隔日照射を行った。15日後にマウス背部の皮膚の伸び(伸張)を吸引法で、又、皮膚の厚み(肥厚)を超音波測定機器を用いてそれぞれ測定した。又、炎症の評価指標としてサイトカインの1つであるMCP−1(Macrophage Chemoattractant protein−1)の血漿中濃度をMCP−1特異的ELISAキット(ENDOGEN社製)を用いて測定した。C57BL / 6J male mice (5 weeks old) (manufactured by Japan SLC Co., Ltd.) were preliminarily raised for 1 week, and each group was divided into 8 groups, divided into a normal group, an ultraviolet irradiation group (control group), and a test substance administration group ( 8 groups for each test group). Feed and water were ad libitum during the test period. The back of the mouse was depilated, and after 2 days, the test substance solution suspended in distilled water for the normal group and the control group, and distilled water for the test substance-administered group was used for 2 days a day using a stomach tube. For 2 weeks, 0.1 mL per 10 g of mouse body weight was forcibly orally administered. The dose of the test substance was 50 mg / kg body weight x 2 times / day for each of thioctic acid, thioctic acid lipid coating and thioctic acid double coating, N-acetyl-D-glucosamine, N-acetylchitooligosaccharide and N The mixture of -acetyl-D-glucosamine was 500 mg / kg body weight each. UV irradiation was performed 4 days after hair removal treatment with a UVB lamp (manufactured by Ieda Trading Co., Ltd., model: T-15M, 15 W type, UV wavelength: 312 nm, UV intensity: 1,000 μW / cm 2 ) 50 cm away from the back of the mouse. 5 days after irradiation for 20 minutes a day, and thereafter, irradiation was performed every other day under the same conditions. After 15 days, the elongation (elongation) of the skin on the back of the mouse was measured by a suction method, and the thickness (thickening) of the skin was measured using an ultrasonic measuring device. In addition, as an evaluation index for inflammation, the plasma concentration of MCP-1 (Macrophage Chemotactic protein-1), which is one of cytokines, was measured using an MCP-1 specific ELISA kit (manufactured by Endogen).

これらの結果を表1(皮膚の伸張、測定単位:mm)、表2(皮膚の肥厚、測定単位:μm)及び表3(血漿中MCP−1濃度、測定単位:pg/mL)に示す。各表において、NAGはN−アセチル−D−グルコサミン、NCOはN−アセチルキトオリゴ糖を示し、数値は正常群の平均値を100としたときの相対値で表示した。The results are shown in Table 1 (skin elongation, measurement unit: mm), Table 2 (skin thickening, measurement unit: μm) and Table 3 (plasma MCP-1 concentration, measurement unit: pg / mL). In each table, NAG represents N-acetyl-D-glucosamine, NCO represents N-acetylchitooligosaccharide, and the numerical values were expressed as relative values when the average value of the normal group was 100.

表1より、紫外線(UV−B)照射によってコントロール群では皮膚の伸び(柔軟性、張り、弾力性)は低下したが、チオクト酸類(チオクト酸、その脂質被覆物、二重被覆物)を経口投与すると顕著に改善され、キチン加水分解物(N−アセチル−D−グルコサミン、これとN−アセチルキトオリゴ糖との混合物)でも若干有効であることが明らかになった。とりわけ前記のチオクト酸類とキチン加水分解物とを組み合わせた場合は、皮膚の伸張が紫外線を照射しない正常群の値まで回復しており、顕著な改善効果が確認された。又、この試験において、紫外線照射以前に試験物質を投与した点を考慮すると、予防効果も大いに期待できる。From Table 1, the skin growth (flexibility, tension, elasticity) in the control group was reduced by ultraviolet (UV-B) irradiation, but thioctic acids (thioctic acid, its lipid coating, double coating) were administered orally. It was clarified that administration improved significantly, and chitin hydrolyzate (N-acetyl-D-glucosamine, a mixture of this and N-acetylchitooligosaccharide) was also slightly effective. In particular, when the thioctic acids and chitin hydrolyzate were combined, the stretch of the skin was restored to the value of the normal group not irradiated with ultraviolet rays, and a remarkable improvement effect was confirmed. In addition, in this test, the preventive effect can be greatly expected in consideration of the administration of the test substance before the ultraviolet irradiation.

表2のデータから、紫外線(UV−B)を照射すると皮膚が著しく肥厚する(コントロール群)が、チオクト酸類を経口投与することによって肥厚(皮膚硬化)症状を顕著に抑制できることが明らかになった。なお、N−アセチル−D−グルコサミンやN−アセチルキトオリゴ糖等のキチン加水分解物を単独で経口投与しても皮膚の肥厚を低減させる効果は認められなかったが、これらとチオクト酸類を併用すると相乗的改善効果も認められた。又、前記の皮膚伸張の場合と同様に、チオクト酸類は経口摂取による皮膚の肥厚症状の予防にとっても有望である。From the data in Table 2, it has been clarified that when ultraviolet rays (UV-B) are irradiated, the skin is markedly thickened (control group), but thickening (skin sclerosis) symptoms can be remarkably suppressed by oral administration of thioctic acids. . In addition, even if chitin hydrolyzate such as N-acetyl-D-glucosamine or N-acetylchitooligosaccharide was orally administered alone, the effect of reducing skin thickening was not recognized, but these and thioctic acids were used in combination. Then, a synergistic improvement effect was also recognized. As in the case of the above-described skin stretching, thioctic acids are also promising for the prevention of skin thickening symptoms caused by oral intake.

更に、表3から、紫外線照射による皮膚炎症を亢進するサイトカインのMCP−1分泌は、N−アセチル−D−グルコサミンやN−アセチルキトオリゴ糖等のキチン加水分解物を経口投与した場合に顕著に低下した。このことから、炎症の悪化に対するキチン加水分解物及びこれとチオクト酸類との併用の有効性(改善及び予防)が期待できる。Furthermore, from Table 3, MCP-1 secretion of a cytokine that enhances skin inflammation caused by ultraviolet irradiation is markedly observed when a chitin hydrolyzate such as N-acetyl-D-glucosamine or N-acetylchitooligosaccharide is orally administered. Declined. From this, the effectiveness (improvement and prevention) of chitin hydrolyzate and its combined use with thioctic acids against the worsening of inflammation can be expected.

Figure 2007145794
Figure 2007145794

Figure 2007145794
Figure 2007145794

Figure 2007145794
Figure 2007145794

(実施例1:飲食品)
チオクト酸(ドイツ・デグサ社製、商品名:ALIPURE(登録商標)、ラセミ体)170部、ミツロウ30部及び中鎖脂肪酸トリグリセリド(日清オイリオ(株)、商品名:ODO(登録商標)50部を約50℃に加熱混合して均質にした後、カプセル充填機に供して、常法により1粒あたり内容量が300mgのゼラチン被覆ソフトカプセル製剤を試作した。このカプセル製剤は経口摂取できる栄養補助食品として利用できる。
(Example 1: Food and drink)
Thioctic acid (manufactured by Degussa, Germany, trade name: ALIPURE (registered trademark), racemic) 170 parts, beeswax 30 parts and medium-chain fatty acid triglyceride (Nisshin Eulio Co., Ltd., trade name: ODO (registered trademark) 50 parts) The mixture was heated and mixed to about 50 ° C. to be homogenized, and then subjected to a capsule filling machine, and a gelatin-coated soft capsule preparation having an internal volume of 300 mg per tablet was prepared by a conventional method. Available as

(実施例2:飲食品)
実施例1において、チオクト酸170部をチオクト酸100部及びキチン加水分解物(試料10)70部に置きかえて同様に処理して栄養補助食品を試作した。
(Example 2: Food and drink)
In Example 1, a dietary supplement was prepared by replacing 170 parts of thioctic acid with 100 parts of thioctic acid and 70 parts of chitin hydrolyzate (sample 10).

(実施例3:飲食品)
実施例1において、チオクト酸170部をキチン加水分解物(試料10)170部に置きかえて同様に処理して栄養補助食品を試作した。
(Example 3: Food and drink)
In Example 1, 170 parts of thioctic acid was replaced with 170 parts of chitin hydrolyzate (sample 10), and the same treatment was performed to produce a nutraceutical product.

(実施例4:飲食品)
チオクト酸脂質被覆物(試料1)75部、キチン加水分解物(試料9)75部、アカショウマエキス末(ビーエイチエヌ(株)製)20部、ミツロウ30部及び月見草油50部の割合の原料を約45℃で十分に混合して均質な状態にした後、カプセル充填機に供して、常法により1粒あたりの内容量が250mgのゼラチン被覆カプセル製剤を試作した。このカプセル製剤は栄養補助食品として経口摂取できるものである。
(Example 4: Food and drink)
About 75 parts of thioctic acid lipid coating (sample 1), 75 parts of chitin hydrolyzate (sample 9), 20 parts of red pepper extract powder (manufactured by BN Co., Ltd.), 30 parts of beeswax and 50 parts of evening primrose oil After thoroughly mixing at 45 ° C. to obtain a homogeneous state, the mixture was supplied to a capsule filling machine, and a gelatin-coated capsule preparation with an inner volume of 250 mg per grain was prepared by a conventional method. This capsule preparation can be taken orally as a dietary supplement.

(実施例5:飲食品)
チオクト酸脂質被覆物(試料2)47部、ブドウ種子エキス(キッコーマン(株)製、「グラビノール」)20部、シスチン25部、ハス胚芽エキス末(丸善製薬(株)製)20部、クレアチン(ドイツ・デグサ社製、「クレアピュア」)25部、リボフラビン(DSMニュートリション・ジャパン(株)製)7部、マルチトール(東和化成(株)製)105部、リン酸三カルシウム(米山化学工業(株)製)105部及びセルロース26部を混合機に仕込み、10分間攪拌混合した。この混合物を直打式打錠機に供して直径7mm、高さ4mm、重量150mg/個の素錠を作成し、ついでコーティング機でシェラック被膜を形成させて錠剤形状の食品を試作した。
(Example 5: Food and drink)
47 parts of thioctic acid lipid coating (sample 2), 20 parts of grape seed extract (manufactured by Kikkoman Corporation, “Grabinol”), 25 parts of cystine, 20 parts of lotus germ extract powder (manufactured by Maruzen Pharmaceutical Co., Ltd.), creatine ( Germany, Degussa, "Crea Pure") 25 parts, Riboflavin (DSM Nutrition Japan Co., Ltd.) 7 parts, Maltitol (Towa Kasei Co., Ltd.) 105 parts, Tricalcium phosphate (Yoneyama Chemical Industries ( Co., Ltd.) 105 parts and cellulose 26 parts were charged in a mixer and stirred and mixed for 10 minutes. This mixture was subjected to a direct compression tableting machine to prepare uncoated tablets having a diameter of 7 mm, a height of 4 mm, and a weight of 150 mg / piece, and then a shellac film was formed by the coating machine to produce a tablet-shaped food.

(実施例6:飲食品)
市販のオレンジジュース1Lに本発明のチオクト酸二重被覆物(試料5)20g及びキチン加水分解物(試料9)を加えて十分に混合し均質なオレンジ風味飲料を試作した。これは冷蔵庫で1週間保存しても外観及び風味に異状及び違和感は認められなかった。
(Example 6: Food and drink)
20 g of the thioctic acid double coating (sample 5) of the present invention and chitin hydrolyzate (sample 9) were added to 1 L of commercially available orange juice and mixed well to produce a homogeneous orange flavored drink. Even if this was stored for 1 week in the refrigerator, no abnormality or discomfort was observed in the appearance and flavor.

本発明のチオクト酸類及び/又はキチン加水分解物を含有してなる組成物は、これを経口や経管で摂取することにより、紫外線とりわけUV−B照射によってひき起こされる皮膚の伸び(伸張)、肥厚(硬化)、炎症等の障害を改善及び/又は予防することができるため、紫外線対策の飲食品、医薬品、化粧品、飼料等の有効利用できる。The composition comprising the thioctic acid and / or chitin hydrolyzate of the present invention is obtained by ingesting it orally or by tube, and elongating (stretching) the skin caused by ultraviolet rays, particularly UV-B irradiation, Since it is possible to improve and / or prevent disorders such as thickening (hardening) and inflammation, it is possible to effectively use foods, medicines, cosmetics, feeds, etc. that are UV-resistant.

Claims (10)

チオクト酸類及び/又はキチン加水分解物を有効成分として含有してなることを特徴とする、紫外線照射による皮膚障害の改善及び/又は予防のための組成物。  A composition for improving and / or preventing skin damage caused by ultraviolet irradiation, comprising a thioctic acid and / or chitin hydrolyzate as an active ingredient. チオクト酸類がチオクト酸、その還元体、光学ラセミ体、それらの塩、エステル並びにアミド、及びこれらのシクロデキストリン包接物からなる群から選ばれる1種又は2種以上のものである請求項1に記載の皮膚障害の改善及び/又は予防のための組成物。  The thioctic acid is one or more selected from the group consisting of thioctic acid, its reduced form, optical racemate, their salts, esters and amides, and these cyclodextrin inclusions. The composition for improvement and / or prevention of the skin disorder as described. チオクト酸類が、チオクト酸、その還元体、光学ラセミ体、それらの塩、エステル並びにアミド、及びこれらのシクロデキストリン包接物からなる群から選ばれる1種又は2種以上の結晶,粉末及び/又は粒子の外表面を脂質類で被覆してなるものである請求項1又は2に記載の皮膚障害の改善及び/又は予防のための組成物。  Thioctic acids are one or more crystals, powders and / or selected from the group consisting of thioctic acid, reduced forms thereof, optical racemates, salts, esters and amides thereof, and cyclodextrin inclusion products thereof. The composition for improving and / or preventing skin disorders according to claim 1 or 2, wherein the outer surface of the particles is coated with lipids. キチン加水分解物が、キチンを酸及び酵素の少なくとも一方を用いて加水分解処理して得られるものである請求項1に記載の皮膚障害の改善及び/又は予防のための組成物。  The composition for improving and / or preventing skin disorders according to claim 1, wherein the chitin hydrolyzate is obtained by hydrolyzing chitin with at least one of an acid and an enzyme. キチン加水分解物がN−アセチルキトオリゴ糖及び/又はN−アセチルグルコサミンを主たる成分として含有するものである請求項1又は4に記載の皮膚障害の改善及び/又は予防のための組成物。  The composition for improving and / or preventing skin disorders according to claim 1 or 4, wherein the chitin hydrolyzate contains N-acetylchitooligosaccharide and / or N-acetylglucosamine as main components. 皮膚障害が皮膚の炎症、硬化、肥厚及び肌荒れのうち少なくとも1つの症状を呈するものである請求項1〜5に記載の皮膚障害の改善及び/又は予防のための組成物。  The composition for improving and / or preventing skin disorders according to claim 1, wherein the skin disorders exhibit at least one symptom of skin inflammation, hardening, thickening and rough skin. 請求項1〜6のいずれか1項に記載の組成物を含有してなることを特徴とする皮膚障害の改善及び/又は予防のための経口用組成物。  An oral composition for improving and / or preventing skin disorders, comprising the composition according to any one of claims 1 to 6. 経口用組成物が飲食品である請求項7に記載の経口用組成物。  The oral composition according to claim 7, wherein the oral composition is a food or drink. 紫外線照射によるヒトの皮膚障害を改善及び/又は予防するために、チオクト酸類及び/又はキチン加水分解物を使用する方法。  A method of using thioctic acids and / or chitin hydrolyzate for improving and / or preventing human skin damage caused by ultraviolet irradiation. 使用する方法が経口摂取又は経口投与である請求項9に記載の方法。  The method according to claim 9, wherein the method used is oral ingestion or oral administration.
JP2006047436A 2005-11-06 2006-01-28 Composition for improving and / or preventing skin disorders Expired - Fee Related JP5023311B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2006047436A JP5023311B2 (en) 2005-11-06 2006-01-28 Composition for improving and / or preventing skin disorders

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2005349921 2005-11-06
JP2005349921 2005-11-06
JP2006047436A JP5023311B2 (en) 2005-11-06 2006-01-28 Composition for improving and / or preventing skin disorders

Publications (2)

Publication Number Publication Date
JP2007145794A true JP2007145794A (en) 2007-06-14
JP5023311B2 JP5023311B2 (en) 2012-09-12

Family

ID=38207633

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006047436A Expired - Fee Related JP5023311B2 (en) 2005-11-06 2006-01-28 Composition for improving and / or preventing skin disorders

Country Status (1)

Country Link
JP (1) JP5023311B2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009108018A (en) * 2007-10-30 2009-05-21 Bhn Kk Ultraviolet resistivity enhancer and use thereof

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07188304A (en) * 1993-11-11 1995-07-25 Asta Medica Ag Clathrate compound, production of teeth-crushable or foamingtablet, and granule and teeth-crushable or foaming tablet
JPH107541A (en) * 1996-06-20 1998-01-13 Noevir Co Ltd Skin lotion
JP2004519483A (en) * 2001-03-06 2004-07-02 バイヤースドルフ・アクチエンゲゼルシヤフト Active ingredient combination consisting of α-lipoic acid and a dermatologically compatible substance absorbing light in the UV-A and / or UV-B wavelength range for producing cosmetic or dermatological preparations Use of things
WO2004064800A1 (en) * 2003-01-23 2004-08-05 Cognis France S.A. Use of oligoglucosamines in cosmetic or dermatological preparations
JP2004250372A (en) * 2003-02-20 2004-09-09 Fancl Corp Skin aging inhibitor/improver and/or rough skin inhibitor/improver kit
JP2006321732A (en) * 2005-05-18 2006-11-30 Fancl Corp Removal of abnormal protein, and composition for suppressing increase of 8-hydroxy-2'-deoxyguanosine

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07188304A (en) * 1993-11-11 1995-07-25 Asta Medica Ag Clathrate compound, production of teeth-crushable or foamingtablet, and granule and teeth-crushable or foaming tablet
JPH107541A (en) * 1996-06-20 1998-01-13 Noevir Co Ltd Skin lotion
JP2004519483A (en) * 2001-03-06 2004-07-02 バイヤースドルフ・アクチエンゲゼルシヤフト Active ingredient combination consisting of α-lipoic acid and a dermatologically compatible substance absorbing light in the UV-A and / or UV-B wavelength range for producing cosmetic or dermatological preparations Use of things
WO2004064800A1 (en) * 2003-01-23 2004-08-05 Cognis France S.A. Use of oligoglucosamines in cosmetic or dermatological preparations
JP2004250372A (en) * 2003-02-20 2004-09-09 Fancl Corp Skin aging inhibitor/improver and/or rough skin inhibitor/improver kit
JP2006321732A (en) * 2005-05-18 2006-11-30 Fancl Corp Removal of abnormal protein, and composition for suppressing increase of 8-hydroxy-2'-deoxyguanosine

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009108018A (en) * 2007-10-30 2009-05-21 Bhn Kk Ultraviolet resistivity enhancer and use thereof

Also Published As

Publication number Publication date
JP5023311B2 (en) 2012-09-12

Similar Documents

Publication Publication Date Title
JP5119509B2 (en) Activity motivator
JP5157001B2 (en) Stabilized α-lipoic acid composition and use thereof
JP6205616B2 (en) Beautiful skin promoter and its use
EP2654463B1 (en) Antioxidants in fish oil powder and tablets
JP6605508B2 (en) Bioactive agents contained in functionalized starches having a single helix V structure
JP4437319B2 (en) Preventing lactic acid production during exercise
JP4556061B2 (en) Hyaluronic acid production enhancer
JP2008239547A (en) Plant-derived activator and extracellular matrix production promoter
JP5157007B2 (en) Bone strengthening agent
JP2014019660A (en) Active oxygen inhibitor
EP1795191A1 (en) Oral pharmaceutical for dry skin prevention or remedy
JPWO2009048120A1 (en) Astaxanthin-containing water-soluble composition
Li et al. Health benefits of astaxanthin and its encapsulation for improving bioavailability: A review
JP5044767B2 (en) Pigmentation inhibitor and use thereof
JP2009108019A (en) External preparation for skin for enhancing ultraviolet resistivity
JP5023311B2 (en) Composition for improving and / or preventing skin disorders
WO2012157290A1 (en) Prophylactic/ameliorating agent for non-alcoholic steatohepatitis
Santos-Sánchez et al. Astaxanthin and its Formulations as Potent Oxidative Stress Inhibitors.
JP4981327B2 (en) UV absorber
JP5245061B2 (en) Oral antioxidant and beauty method
JP2009108018A (en) Ultraviolet resistivity enhancer and use thereof
JP2012246244A (en) Capillary regression inhibitor
JP2004107242A (en) Kit for improving dry skin
JP2004248643A (en) Transparent base and use thereof
JP2006315995A (en) Water-soluble thioctic acid-containing composition and method for producing the same

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20090126

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20111220

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120220

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20120515

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20120521

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20150629

Year of fee payment: 3

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

Ref document number: 5023311

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees